Memphis Pharmaceuticals & Chemical Industries Share Price
Equities
MPCI
EGS38351C010
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
97.95 EGP | +11.23% | +6.32% | +56.20% |
Sales 2022 | 551M 11.51M 960M | Sales 2023 | 664M 13.86M 1.16B | Capitalization | 174M 3.64M 303M |
---|---|---|---|---|---|
Net income 2022 | 74M 1.54M 129M | Net income 2023 | 90M 1.88M 157M | EV / Sales 2022 | - |
Net cash position 2022 | 79.1M 1.65M 138M | Net cash position 2023 | 130M 2.72M 227M | EV / Sales 2023 | 0.07 x |
P/E ratio 2022 |
1.05
x | P/E ratio 2023 |
1.93
x | Employees | 144 |
Yield 2022 * |
-
| Yield 2023 |
6.46% | Free-Float | 30% |
1 day | +11.23% | ||
1 week | +6.32% | ||
Current month | -0.33% | ||
1 month | -2.94% | ||
3 months | +19.79% | ||
6 months | +69.90% | ||
Current year | +56.20% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | - | |
Heba Samir
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Chairman | - | - | |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 95.25 | +0.80% | 31,804 |
01/24/01 | 94.49 | -3.53% | 60,084 |
30/24/30 | 97.95 | +11.23% | 89,060 |
29/24/29 | 88.06 | +1.07% | 11,837 |
28/24/28 | 87.13 | -3.89% | 7,013 |
End-of-day quote Egyptian Exchange, April 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+56.20% | 11.17M | |
+29.68% | 681B | |
+20.01% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.34% | 235B | |
+4.39% | 199B | |
-11.78% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- MPCI Stock